267 related articles for article (PubMed ID: 22895449)
1. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial dysfunction in patients with newly diagnosed type 2 diabetes and effects of 2-year and 5-year multifactorial intervention.
Tian J; Wen Y; Yan L; Cheng H; Yang H; Wang J; Kozman H; Villarreal D; Liu K
Echocardiography; 2011 Nov; 28(10):1133-40. PubMed ID: 21967242
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
Chan DC; Wong AT; Yamashita S; Watts GF
Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
Lee SJ; Lee DW; Kim KS; Lee IK
Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
Hamilton SJ; Chew GT; Davis TM; Watts GF
Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
Yu Y; Suo L; Yu H; Wang C; Tang H
Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
[TBL] [Abstract][Full Text] [Related]
8. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study.
Li F; Zhao T; Wen X
Diabetes Res Clin Pract; 2011 Nov; 94(2):186-92. PubMed ID: 21871685
[TBL] [Abstract][Full Text] [Related]
10. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).
Goldfine AB; Buck JS; Desouza C; Fonseca V; Chen YD; Shoelson SE; Jablonski KA; Creager MA;
Diabetes Care; 2013 Dec; 36(12):4132-9. PubMed ID: 24130358
[TBL] [Abstract][Full Text] [Related]
11. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X.
Kayaalti F; Kalay N; Basar E; Mavili E; Duran M; Ozdogru I; Dogan A; Inanc MT; Kaya MG; Topsakal R; Oguzhan A
Heart Vessels; 2010 Mar; 25(2):92-6. PubMed ID: 20339969
[TBL] [Abstract][Full Text] [Related]
12. Impact of endothelin blockade on acute exercise-induced changes in blood flow and endothelial function in type 2 diabetes mellitus.
Schreuder TH; van Lotringen JH; Hopman MT; Thijssen DH
Exp Physiol; 2014 Sep; 99(9):1253-64. PubMed ID: 24928953
[TBL] [Abstract][Full Text] [Related]
13. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
Emoto T; Sawada T; Hashimoto M; Kageyama H; Terashita D; Mizoguchi T; Mizuguchi T; Motodi Y; Iwasaki M; Taira K; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
Am J Cardiol; 2012 Jan; 109(1):42-6. PubMed ID: 21944671
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
[TBL] [Abstract][Full Text] [Related]
15. Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients.
Xiang G; Zhang J; Ling Y; Zhao L
Clin Endocrinol (Oxf); 2014 Feb; 80(2):228-34. PubMed ID: 23931066
[TBL] [Abstract][Full Text] [Related]
16. Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas.
Naka KK; Papathanassiou K; Bechlioulis A; Pappas K; Kazakos N; Kanioglou C; Kostoula A; Vezyraki P; Makriyiannis D; Tsatsoulis A; Michalis LK
Diab Vasc Dis Res; 2012 Jan; 9(1):52-8. PubMed ID: 22049096
[TBL] [Abstract][Full Text] [Related]
17. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Nyström T; Gutniak MK; Zhang Q; Zhang F; Holst JJ; Ahrén B; Sjöholm A
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1209-15. PubMed ID: 15353407
[TBL] [Abstract][Full Text] [Related]
19. Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research.
Irace C; De Luca S; Shehaj E; Carallo C; Loprete A; Scavelli F; Gnasso A
Diab Vasc Dis Res; 2013 Jan; 10(1):72-7. PubMed ID: 22732108
[TBL] [Abstract][Full Text] [Related]
20. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.
Martens FM; Visseren FL; de Koning EJ; Rabelink TJ
J Cardiovasc Pharmacol; 2005 Dec; 46(6):773-8. PubMed ID: 16306801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
